Abstract Background -The relationship between cell types in bronchoalveolar lavage (BAL) fluid and the clinical course of patients with idiopathic pulmonary fibrosis (IPF) has been the subject of several studies. However, the results of these studies are not conclusive. The aim of this study was to investigate the relationship between the absolute and relative cell numbers in BAL fluid from patients with IPF and their survival. Methods -Results obtained from the initial BAL fluid analyses of all histologically proven cases of IPF (n = 49) were selected retrospectively. Cox's proportional hazards survival analysis was used for estimating the relationship between absolute and relative cell numbers and survival. Results -A negative relationship was found between both the absolute numbers and percentages of eosinophils in BAL fluid samples and survival. No such relationship was demonstrated for the absolute numbers or the percentages of any other cell type. Conclusions -Although this study has restrictions, these findings suggest a negative relationship between the absolute numbers and percentages ofeosinophils in BAL fluid samples and survival in patients with IPF.
Idiopathic pulmonary fibrosis (IPF) is a chronic, often progressive, interstitial lung disease. Although experimental studies have partly clarified several signalling mechanisms leading to the interstitial fibrotic process, an underlying cause for the accumulation of fibrous tissue has not been established. In lung biopsy specimens several cell types have been found in the interstitium as well as in the alveolar spaces. These cells are able to release various cell products including cytokines and toxic proteins which play a part in the inflammatory process, as well as in the proliferation of fibroblasts and collagen synthesis. Despite a difference in quality and quantity of the mediated cellular and extracellular components, the result of this ongoing reparative response, which originates in the interstitium, is often non-functioning tissue. The original architecture of pulmonary parenchyma is lost and replaced by fibrotic tissue with deformation of bronchioli.
In previous studies ofbronchoalveolar lavage (BAL) fluid samples from patients with IPF, the total cell count was found to be increased compared with control subjects when the smoking status of both patients and controls was taken into account.' Additionally, the percentages of polymorphonuclear neutrophils and eosinophils were also raised compared with control subjects.'2 Results concerning the mast cell count in BAL fluid of patients with IPF compared with controls were not conclusive. 3`6 No significant difference was demonstrated in the percentages of lymphocytes between patients with IPF and controls. '2 To our knowledge, the relationship between BAL fluid analysis and survival in patients with IPF has been investigated in only one study. 7 In this study no Cox's proportional hazards model was used for analysing the dependency of mortality on the risk factors.'6 As entry time we used the time at which BAL was performed. The end point was death due to all causes. The follow up ended in September 1992. As explanatory variables the following were considered: the percentages and absolute cell numbers of alveolar macrophages, lymphocytes, neutrophils, eosinophils, and mast cells in BAL fluid samples and their quadratic terms. Additionally, we also considered the effects of age, sex, smoking, and corticosteroid therapy at the time BAL was performed. The contribution of these variables to the model was tested by means of the likelihood ratio test.
The Mann-Whitney U test was used to evaluate differences in the cellular analysis of BAL fluid samples between patients with IPF and the control subjects. The same test was used to evaluate the results between different categories of patients with IPF, constituted by smoking and corticosteroid therapy at the time BAL was performed. A p value less than 0 05 was considered to be significant.
Results

FOLLOW UP
During the follow up period 24 patients died, their mean survival being 3-7 years (range 0 1-12-2 years). Fourteen patients died from respiratory insufficiency due to pulmonary fibrosis, five died from causes associated with pulmonary fibrosis (three from pulmonary infection, one from pulmonary embolism, one from lung cancer). Three patients died due to cardiovascular diseases and two from other causes. At the end of the follow up period (September 1992) 25 patients were still alive. Their follow up period ranged from 2-6 to 1 2-1 years (mean 8 9) . No patients were lost to follow up.
Patients were treated by a team ofpulmonary physicians. All patients were initially treated with high doses of corticosteroids for several weeks. The maintenance of treatment depended on the clinical course. Patients with rapid progression of disease (decline in lung function, shortness of breath at rest and/or hypoxia within three months after corticosteroid therapy was started, or within three months after the dose of corticosteroids was increased to 50 mg daily) were additionally treated with azathioprine or cyclophosphamide. In patients who were stable the corticosteroid treatment was reduced to a maintenance level of between 5 and 10 mg prednisone daily. In patients whose clinical condition improved, further effort was made to minimise the steroid dose. Fourteen of the 19 patients who died from causes associated with pulmonary fibrosis were treated with cytotoxic drugs. Only three of the 25 patients still alive at the end of the follow up were treated with cytotoxic drugs.
CELLULAR ANALYSIS
The absolute numbers of neutrophils, eosinophils, and mast cells in BAL fluid samples of the patients with IPF were significantly higher than the control subjects (p<0001, p<0001 and p<002, respectively) when the smoking history was taken into account. Table 3 Percentages of cells in bronchoalveolar lavage fluid samples obtained from patients with idiopathic pulmonary fibrosis (IPF) (n = 49) and control subjects (n = 30) In a separate study we investigated lung biopsy material from 29 IPF patients, comparing the cellularity and the degree and the extent of fibrosis with the BAL cell profile. No relationship was found between any of the cell types (including eosinophils) and the histological picture (data not shown). This is consistent with the study by Watters et al who found no correlation between BAL fluid eosinophil content and histopathological abnormalities, although a possible relationship between BAL eosinophilia and the presence ofhoneycombing was suggested.'2 In patients with fibrosing alveolitis in systemic sclerosis, which is histologically identical to lone idiopathic pulmonary fibrosis, Wells and coworkers studied the relationship between BAL findings and the pattern and extent of the disease, judged by thin section computed tomographic (CT) scanning." Significantly increased BAL eosinophil counts were found in early as well as in advanced disease, with a relationship between the percentage of eosinophils and the extent of a ground glass pattern on CT, suggesting inflammatory histological appearances. However, survival was better in fibrosing alveolitis associated with systemic sclerosis than in idiopathic pulmonary fibrosis.24 Fibrosing alveolitis may have different pathogenic mechanisms in the two diseases, causing the difference in survival. Whether eosinophils are (partly) responsible for the damage to the alveoli in IPF or BAL eosinophilia reflects advanced disease remains to be established.
In this present study there was a negative relationship between age and survival. When the absolute number or the percentage of eosinophils was included as an explanatory variable in the model, together with the variable of age, both variables lost their significant effect. No relationship was found between eosinophils and survival. In both models the shape of the relationship of mortality with eosinophils does not essentially change, either with or without age as an explanatory variable in the model. It is likely that the sample size is too small to reach statistical significance in a model with more explanatory variables.
One of the limitations of the study is that approximately 40% of the patients were receiving corticosteroids at the time BAL was performed. Although no relationship was demonstrated between corticosteroid treatment at the time BAL was performed and survival, therapy may have influenced BAL findings.'0 Survival analysis of the untreated group (27 patients) showed a tendency for a negative relationship between the absolute numbers of eosinophils and survival, but the results were not significant. It is likely that the number of patients is too small to reach statistically significant results in this model.
Schwartz et al did not find a relationship between BAL findings and survival in IPF patients,7 although a higher concentration of lymphocytes appeared to be independently associated with slightly improved survival in a subgroup of their patients. They studied 74 patients, approximately 40% ofwhom were also receiving corticosteroid treatment, one third in combination with cyclophosphamide. In their study the male/female ratio was almost similar to that described here, while the average age was slightly higher. There were no racial differences between both groups. They analysed survival from onset of symptoms and not from the time BAL was performed. This was done in order to adjust for the variable length of time between onset of symptoms and time of diagnosis. If we analysed our data with survival from the time of onset of symptoms, we found not only a relationship between the absolute number and percentage of eosinophils and survival but also a relationship between the absolute number and percentage of neutrophils and survival. It is plausible that response of treatment and progression of disease may have altered BAL findings. Schwartz and coworkers performed a hierarchical multivariate analysis on the factors that were found to be significantly associated with diminished survival in IPF, to assess the relative independence of these associated factors. Since the number of patients in our study was too small, we were not able to perform such an analysis.
In contrast to our study, 
